Recall Register

Drug recall: Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC…

Class II FDA enforcement event 80041. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Defective delivery system

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

L. Perrigo Company started this drug recall on 11 May 2018. The firm address in the FDA record is in Allegan, MI. FDA put the recall in Class II. FDA event 80041 has 1 product record. The first FDA enforcement report date is 23 May 2018. The record gives the status Terminated, with the termination date 28 Sep 2020. 128 of the 367 drug events that started in 2018 have more product records. The median drug event of 2018 has 1 product record. The openFDA file has 367 drug events that started in 2018 and 343 that started in 2017.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the U.S.A.

Recalling firm

L. Perrigo Company, Allegan, MI.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 80041: product records
Recall numberProductQuantityClassStatusReport date
D-0816-2018Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46); c) 24-count (NDC 45802-580-62), Rx only, Mfd. by: Aveva Drug Delivery Systems, A Nitto Denko Company, Miramar, FL 33025 Distributed by Perrigo, Allegan, MI 49010569,520 cartonsClass IITerminated23 May 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2018
367
Share of these events in Class II
60%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
8

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 80041. https://recallregister.com/fda/ii/80041/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the U.S.A.
What quantity of product is in FDA event 80041?
The FDA record gives this quantity: 569,520 cartons
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2018 have the same class?
60% of the 367 drug events that started in 2018 are in Class II.